Complications associated with catheter ablation of atrial fibrillation

Minerva Cardioangiologica

Volumn 55, Issue 3, 2007, Pages 353-368

  Dhruvakumar, S ^a   Gerstenfeld, E P ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b 9 Founders Pavilion ^*  (United States)

Author keywords

Atrial fibrillation; Catheter ablation; Postoperative complications

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN; PROTAMINE;

ARTERIOVENOUS FISTULA; AUTONOMIC DYSFUNCTION; CATHETER ABLATION; CORONARY ARTERY SPASM; DOSE RESPONSE; EMBOLISM; ESOPHAGUS FISTULA; FALSE ANEURYSM; HEART ATRIUM FIBRILLATION; HEART SEPTUM DEFECT; HEMATOMA; HUMAN; LUNG VEIN OBSTRUCTION; MUSCLE DENERVATION; NERVE INJURY; PERICARDIAL EFFUSION; RADIATION INJURY; REVIEW; RISK ASSESSMENT; STROKE; SUPRAVENTRICULAR TACHYCARDIA; TRANSIENT ISCHEMIC ATTACK;

ANEURYSM, FALSE; ARTERIOVENOUS FISTULA; ATRIAL FIBRILLATION; CARDIAC TAMPONADE; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; HEMATOMA; HUMANS; ISCHEMIC ATTACK, TRANSIENT; PERICARDIAL EFFUSION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 34447522047     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Chen LY, Shen WK. Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm 2007;4:S1-S6.
2. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-25.
3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52.
4. Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. J Cardiovasc Electrophysiolo 2006;9:348-56.
5. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF). Lancet 2000;356:1789-94.
6. Kochiadakis GE, Igoumenidis NE, Hamilos ME, Tzerakis PG, Klapsinos NC, Chlouverakis GI et al. Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation. Am J Cardiol 2004;94:563-6.
7. Corley S. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004;109:1509-13.
8. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:257-354.
9. Jais P, Haissaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997;95:572-6.
10. Cheema A, Vasamreddy CR, Dalal D, Marine JE, Dong J, Henrikson CA et al. Long-term single procedure efficacy of catheter ablation of atrial fibrillation. J Interv Card Electrophysiol 2006;15:145-55.
11. Pappone C, Santinelli V. How to perform encircling ablation of the left atrium. Heart Rhythm 2006;3:1105-9.
12. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005;111:1100-5.
13. Stone PA, AbuRahma AF, Flaherty SK, Bates MC. Femoral pseudoaneurysms. Vasc Endovasc Surg 2006;40:109-17.
14. Vasamreddy CR, Dalal D, Eldadah Z, Dickfeld T, Jayam VK, Henrickson C et al. Safety and efficacy of circumferential pulmonary vein catheter ablation of atrial fibrillation. Heart Rhythm 2005;2:42-8.
15. Bunch TJ, Asirvatham SJ, Friedman PA, Monahan KH, Munger TM, Rea RF et al. Outcomes after cardiac perforation during radiofrequency ablation of the atrium. J Cardiovasc Electrophysiol 2005;16:1172-9.
16. Dixit E, Marchlinski FE. How to recognize, manage, and prevent complications during atrial fibrillation ablation. Heart Rhythm 2007;4:108-15.
17. Jais P, Hocini M, Hsu LF, Sanders P, Scavee C, Weerasooriya R et al. Technique and results of linear ablation at the mitral isthmus. Circulation 2004;110:2996-3002.
18. Kesek M, Englund A, Jensen SM, Jensen-Urstad M. Entrapment of circular mapping catheter in the mitral valve. Heart Rhythm 2007;4:17-9.
19. Wu RC, Brinker JA, Yuh DD, Berger RD, Calkins HG. Circular mapping catheter entrapment in the mitral valve apparatus: a previously unrecognized complication of focal atrial fibrillation ablation. J Cardiovasc Electrophysiol 2002;13:819-21.
20. Oral H, Chugh A, Ozaydin M, Good E, Fortino J, Sankaran S et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006;114:759-65.
21. Ren JF, Marchlinski FE, Callans DJ. Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. J Am Coll Cardiol 2004;43:1861-7.
22. Padanilam BJ. Cerebral microembolism during af ablation: an innocent bystander or an accessory to brain injury? J Cardiovasc Electrophysiol 2006;17:502-3.
23. Ren JF, Marchlinski FE, Callans DJ, Gerstenfeld EP, Dixit S, Lin D et al. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J Cardiovasc Electrophysiol 2005;16:474-7.
24. Marrouche NF, Martin DO, Wazni O, Gillinov AM, Klein A, Bhargava M et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation 2003;107:2710-6.
25. Doll N, Borger MA, Fabricius A, Stephan S, Gummert J, Mohr FW et al. Esophageal perforation during left atrial radiofrequency ablation: is the risk too high? J Thorac Cardiovasc Surg 2003;125:836-42.
26. Pappone C, Oral H, Santinelli V, Vicedomini G, Lang CC, Manguso F et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation 2004;109:2724-6.
27. Scanavacca MI, D'avila A, Parga J, Sosa E. Left atrial-esophageal fistula following radiofrequency catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2004;15:960-2.
28. Bunch TJ, Nelson J, Foley T, Allison S, Crandall BG, Osborn JS et al. Temporary Esophageal stenting allows healing of esophageal perforations following atrial fibrillation ablation procedures. J Cardiovasc Electrophysiol 2006;17:435-9.
29. Gerstenfeld EP, Guerra P, Sparks PB, Hattori K, Lesh MD. Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. J Cardiovasc Electrophysiol 2001;12:900-8.
30. Yu WC, Hsu TL, Tai CT, Tsai CF, Hsieh MH, Lin WS et al. Acquired pulmonary vein stenosis after radiofrequency catheter ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2001;12:887-92.
31. Saad EB, Rossillo A, Saad CP, Martin DO, Bhargava M, Erciyes D et al. Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy. Circulation 2003;108:3102-7.
32. Ren JF, Marchlinski FE, Callans DJ, Zado ES. Intracardiac Doppler echocardiographic quantification of pulmonary vein flow velocity: an effective technique for monitoring pulmonary vein ostia narrowing during focal atrial fibrillation ablation. J Cardiovasc Electrophysiol 2002;13:1076-81.
33. Di Biase L, Fahmy TS, Wazni OM, Bai R, Patel D, Lakkireddy D et al. Pulmonary vein total occlusion following catheter ablation for atrial fibrillation: clinical implications after long-term follow-up. J Am Coll Cardiol 2006;48:2493-9.
34. Packer DL, Keelan P, Munger TM, Breen JF, Asirvatham S, Peterson LA et al. Clinical presentation, investigation, and management of pulmonary vein stenosis complicating ablation for atrial fibrillation. Circulation 2005;111:546-54.
35. Purerfellner H, Aichinger J, Martinek M, Nesser HJ, Cihal R, Gschwendtner M. Incidence, management, and outcome in significant pulmonary vein stenosis complicating ablation for atrial fibrillation. Am J Cardiol 2004;93:1428-31.
36. Sacher F, Jais P, Stephenson K, O'Neill MD, Meleze Hocini DP, Clementy J et al. Phrenic nerve injury after catheter ablation of atrial fibrillation. Indian Pacing Electrophysiol J 2007;7:1-6.
37. Shah D, Dumonceau JM, Burri H, Sunthorn H, Schroft A, Gentil-Baron P et al. Acute pyloric spasm and gastric hypomotility: an extracardiac adverse effect of percutaneous radiofrequency ablation for atrial fibrillation. J Am Coll Cardiol 2005;46:327-30.
38. Bauer A, Deisenhofer I, Schneider R, Zrenner B, Barthel P, Karch M et al. Effects of circumferential or segmental pulmonary vein ablation for paroxysmal atrial fibrillation on cardiac autonomic function. Heart Rhythm 2006;3:1428-35.
39. Tada H, Naito S, Oshima S, Taniguchi K. Vasospastic angina shortly after left atrial catheter ablation for atrial fibrillation. Heart Rhythm 2005;2:867-70.
40. Risius T, Lewalter T, Luderitz B, Schwab JO, Spitzer S, Schmitt C et al. Transient ST-segment-elevation during pulmonary vein ablation using circumferential coiled microelectrodes in a prospective multi-centre study. Europace 2006;8:178-81.
41. Takahashi Y, Jais P, Hocini M, Sanders P, Rotter M, Rostock T et al. Acute occlusion of the left circumflex coronary artery during mitral isthmus linear ablation. J Cardiovasc Electrophysiol 2005;16:1104-7.
42. Gerstenfeld EP, Marchlinski FE. Mapping and ablation of left atrial tachycardias occurring after atrial fibrillation ablation. Heart Rhythm 2007;4 (3 Suppl):S65-S72.
43. Deisenhofer I, Estner H, Zrenner B, Schreieck J, Weyerbrock S, Hessling G et al. Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: incidence, electrophysiological characteristics, and results of radiofrequency ablation. Europace 2006;8:573-82.
44. Gerstenfeld EP, Callans DJ, Dixit S, Russo AM, Nayak H, Lin D et al. Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation. Circulation 2004;110:1351-7.
45. Mesas CE, Pappone C, Lang CC, Gugliotta F, Tomita T, Vicedomini G et al. Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: electroanatomic characterization and treatment. J Am Coll Cardiol 2004;44:1071-9.
46. Chugh A, Oral H, Lemola K, Hall B, Cheung P, Good E et al. Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation. Heart Rhythm 2005;2:464-71.
47. Vlietstra RE, Wagner LK, Koenig T, Mettler F. Radiation burns as a severe complication of fluoroscopically guided cardiological interventions. J Cardiovasc Electrophysiol 2004;17:131-42.